Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
2,036.00    30.00 (1.50%)
Bid:
2,036.00
Ask:
2,038.00
Spread: 2.00 (0.098%)
Market Cap: £2.26b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Directorate change

22 Jan 2026 09:00

RNS Number : 9492P
Derwent London PLC
22 January 2026
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

Derwent London plc ("Derwent London" / "the Group")

PAUL WILLIAMS, CHIEF EXECUTIVE, TO RETIRE

Derwent London today announces that Paul Williams has informed the Board of his intention to retire as Chief Executive and Director of the Company.

Paul will remain in his role until his successor is in place at which point he will step down from the Board.

Paul's career at Derwent began shortly after the Company was founded in 1984. He was appointed as an Executive Director in 1998, with responsibility for leasing, asset management and development, and subsequently became Chief Executive in 2019.

A thorough process to appoint a successor, led by the Chairman Mark Breuer, will commence immediately.

Mark Breuer, Chairman, commented: 

"I would like to thank Paul for his dedication and commitment over the last 38 years. During his distinguished career, including his tenure as Chief Executive, he has made an outstanding contribution to Derwent London. With its market leading position, ongoing commitment to capital recycling and significant development pipeline, Derwent London is well placed to create significant value for shareholders."

Paul Williams, Chief Executive, said:

"It has been a huge privilege to have been part of the Derwent story and to have had the opportunity to lead the business over the last six years. I am very proud of what we have achieved, positioning the business with world class assets in prime locations across London, attracting sustained and strong occupational demand. I would like to thank my fellow directors and all the team for their continued hard work and support. I remain fully focused on driving the performance of the business until my successor is in place."

Information equivalent to that required under section 430(2B) of the UK Companies Act 2006 will be made available on the Company's website at the time Paul Williams steps down from the Board and in the Company's 2025 Directors' Remuneration Report.

For further information, please contact:

Derwent London

Tel: +44 (0)20 3478 4217 (Robert Duncan)

Mark Breuer, Chairman

David Lawler, Company Secretary

Robert Duncan, Head of Investor Relations

Brunswick Group

Tel: +44 (0)20 7404 5959

 

 

Simon Sporborg

Nina Coad

Notes to editors

Derwent London plc

Derwent London plc owns a commercial real estate portfolio predominantly in central London valued at £5.2 billion as at 30 June 2025, making it the largest London office-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or City Borders. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 25 Baker Street W1, 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1 and Tea Building E1.

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, publishing its pathway to achieving this goal in 2020. Our science-based carbon targets have been validated by the Science Based Targets initiative (SBTi). In 2013, we launched a voluntary Community Fund which to date has supported 180 community projects in central London.

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

For further information see www.derwentlondon.com or follow us on LinkedIn.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGIGDBIBDDGLD
Date   Source Headline
11th Jul 20164:00 pmRNSNotice of Results
11th Jul 201611:10 amRNSHolding(s) in Company
11th Jul 201611:05 amRNSTotal Voting Rights
8th Jul 20169:30 amRNSDirector/PDMR Shareholding
29th Jun 20169:30 amRNSDirector/PDMR Shareholding
28th Jun 201610:00 amRNSDirector/PDMR Shareholding
27th Jun 20163:15 pmRNSDirector/PDMR Shareholding
23rd Jun 20163:05 pmRNSDirector/PDMR Shareholding
9th Jun 20162:30 pmRNSDirector/PDMR Shareholding
8th Jun 201611:00 amRNSAdditional Listing
2nd Jun 20164:45 pmRNSBlock listing Interim Review
1st Jun 20164:45 pmRNSTotal Voting Rights
1st Jun 20164:45 pmRNSBondholders' Meeting
16th May 20164:15 pmRNSResolutions of the 2016 Annual General Meeting
13th May 20161:00 pmRNSResult of AGM
12th May 20164:30 pmRNSScrip Dividend
5th May 20167:00 amRNSQ1 2016 Business Update
4th May 20169:00 amRNSTotal Voting Rights
21st Apr 20165:15 pmRNSHolding(s) in Company
13th Apr 20161:35 pmRNSDocuments available at NSM
13th Apr 201610:00 amRNSDirector/PDMR Shareholding
13th Apr 201610:00 amRNSDirector/PDMR Shareholding
13th Apr 201610:00 amRNSDirector/PDMR Shareholding
13th Apr 201610:00 amRNSDirector/PDMR Shareholding
13th Apr 201610:00 amRNSDirector/PDMR Shareholding
12th Apr 20165:46 pmRNSDirector/PDMR Shareholding
11th Apr 20162:30 pmRNSBlock listing Interim Review
11th Apr 20162:30 pmRNSBlock listing Interim Review
30th Mar 20164:05 pmRNSDirector/PDMR Shareholding
30th Mar 20164:05 pmRNSDirector/PDMR Shareholding
30th Mar 20164:05 pmRNSDirector/PDMR Shareholding
30th Mar 20164:05 pmRNSDirector/PDMR Shareholding
30th Mar 20164:05 pmRNSDirector/PDMR Shareholding
30th Mar 20164:05 pmRNSDirector/PDMR Shareholding
24th Mar 201612:40 pmRNSHolding(s) in Company
16th Mar 201611:30 amRNSDirector/PDMR Shareholding
26th Feb 20162:45 pmRNSHome Member State
25th Feb 20162:00 pmRNSHolding(s) in Company
25th Feb 20167:01 amRNSMAJOR PRE-LET TO CAPITA AT THE COPYRIGHT BUILDING
25th Feb 20167:01 amRNSDERWENT LONDON £105 MILLION US PRIVATE PLACEMENT
25th Feb 20167:00 amRNSPreliminary Results Announcement
22nd Feb 20165:15 pmRNSNotice of Results
9th Feb 20169:30 amRNSDirector Declaration
1st Feb 201611:15 amRNSHolding(s) in Company
6th Jan 201612:25 pmRNSDirectorate Change
7th Dec 20157:00 amRNSDisposal of Wedge House
1st Dec 20152:25 pmRNSHolding(s) in Company
1st Dec 20152:25 pmRNSTotal Voting Rights
12th Nov 20157:00 amRNSThird quarter Business Update
2nd Nov 20153:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.